RTCT May Redefine What Operational Oversight Looks Like Signals, latency, interoperability, and the future of operational oversight and inspection readiness This article reflects insights and analysis following the FDA Industry Information Session on Real-Time Clinical Trials held on May 15, 2026 from 11:00 AM – 1:00 PM ET. Participants: Jeremy Walsh, Chief AI Officer, FDA Malika Mundkur, […]
